Cargando…
The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
Pulmonary hypertension (PH) in patients with Systemic Sclerosis (SSc) may stem from a variety of underlying causes, thus making a correct diagnosis and management difficult. The main challenges lie in the distinction between pulmonary arterial hypertension (PAH, group 1) and PH due to interstitial l...
Autores principales: | Zanatta, Elisabetta, Marra, Martina Perazzolo, Famoso, Giulia, Balestro, Elisabetta, Giraudo, Chiara, Calabrese, Fiorella, Rea, Federico, Doria, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504220/ https://www.ncbi.nlm.nih.gov/pubmed/36145263 http://dx.doi.org/10.3390/ph15091042 |
Ejemplares similares
-
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Moccaldi, Beatrice, et al.
Publicado: (2023) -
CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023) -
Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
por: Calabrese, Fiorella, et al.
Publicado: (2013) -
Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients
por: Giraudo, Chiara, et al.
Publicado: (2021) -
Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: Case report and review of literature
por: Lunardi, Francesca, et al.
Publicado: (2011)